← FDA Drug Approvals (Drugs@FDA)
NEOSTIGMINE METHYLSULFATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MEITHEAL · Approved 2021-04-05
Drug application
- FDA Application #
ANDA212804- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NEOSTIGMINE METHYLSULFATE
- Generic name
- NEOSTIGMINE METHYLSULFATE
- Active ingredients
- NEOSTIGMINE METHYLSULFATE
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- MEITHEAL
- Manufacturer
- Meitheal Pharmaceuticals Inc.
- First approval
- 2021-04-05
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown